Try our Advanced Search for more refined results
March 04, 2016
ASTRAZENECA AB et al v. HETERO USA INC. et al
Case Number:
3:16-cv-01280
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 07, 2016
Takeda, AstraZeneca Say Indian Co. Infringed Daliresp Patent
An Indian generic drug manufacturer infringed Takeda's and AstraZeneca's patent for the chronic obstructive pulmonary disease drug Daliresp with its recent abbreviated new drug application, according to a lawsuit filed Friday in New Jersey federal court, the latest of about a dozen filed over the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login